UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000014197
Receipt number R000015992
Scientific Title Evaluation of minimal residual disease,immune cells dynamics and quality of life in bortezomib based induction therapy followed by lenalidomide maintenance for newly diagnosed patients with multiple myeloma ineligible for stem cell transplantation.
Date of disclosure of the study information 2014/07/01
Last modified on 2018/04/28 12:18:44

No. Disposal Last modified on Item of update
1 Insert 2014/06/06 20:23:56
2 Update 2018/04/28 12:18:44 UMIN ID1